Name: Latest research reports of Dr. Reddy's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Dr. Reddy's Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Dr. Reddy's Laboratories Ltd.

NSE: DRREDDY | BSE: 500124 | ISIN: INE089A01031 | Industry: Pharmaceuticals
| Mid-range Performer

1220.6000 -49.70 (-3.91%)

NSE Aug 01, 2025 15:31 PM

Volume: 2.5M

Dr. Reddy's Laboratories Ltd.

31 Jan 2022

1220.60

-3.91%

Dr Reddy's Labs (HOLD): Stable quarter, US price erosion continues; cut to HOLD

Hold: Dr. Reddy's Laboratories Ltd.

Target

BOB Capital Markets Ltd.

Growth in Q3 driven by product launches and higher volumes, partly offset by US price erosion

Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.